# Claim table — Jimmy Dore / Angus Dalgleish COVID-cancer YouTube source-check

| Claim | Evidence label | Finding |
|---|---|---|
| The YouTube video exists and is the Jimmy Dore / Angus Dalgleish interview. | Confirmed source claim | YouTube metadata/title/description and saved auto-subtitles confirm the video. |
| The video proves “COVID itself” is the direct cause of cancer. | Not established / unclear framing | The title, description and transcript mostly frame the claim as COVID vaccination/mRNA/spike, not ordinary SARS-CoV-2 infection alone. |
| Dalgleish claims COVID vaccination creates “turbo cancers.” | Confirmed source claim / expert opinion | Transcript says “COVID-19 vaccine induces cancer” and discusses alleged mechanisms. That proves he made the claim, not that the claim is clinically proven. |
| COVID vaccines have been shown to cause cancer, recurrence or progression. | Not established by official oncology guidance | NCI says there is no evidence COVID-19 vaccines cause cancer, lead to recurrence, or lead to disease progression, and that they do not change DNA. |
| COVID infection can be harmful for cancer patients. | Established evidence / official guidance | NCI and oncology literature state people with cancer are at higher risk of severe COVID outcomes and treatment disruption. |
| SARS-CoV-2 infection may have theoretical cancer-related mechanisms. | Hypothesis / mechanistic review | Reviews discuss inflammation, immune dysregulation and possible oncogenic pathways; this is not the same as population-level proof that COVID infection directly causes cancer. |
| Pandemic disruptions caused cancer screening/diagnosis/treatment delays. | Supported evidence | Reviews and studies document pandemic-related delays and disruptions in cancer services; this can worsen stage at diagnosis without proving viral causation. |
| Cancer patients should change cancer treatment or vaccination decisions based on this video. | Unsafe unsupported medical advice | No personal medical instruction is given; decisions require oncology/infectious-disease clinician review. |